J&J Completes Omrix Tender Offer

 

NEW BRUNSWICK, N.J. -- Johnson & Johnson(JNJ Quote) said Saturday that it completed its tender offer for shares of Omrix Biopharmaceuticals Inc.(OMRI Quote), a New York-based maker of liquid sealants used to control bleeding during surgery.

J&J said Omrix shareholders tendered about 97.8% of shares in response to a tender offer that expired at midnight Friday.

The $438 million buyout announced Nov. 24 is aimed at boosting the health-product company's surgical care business.

J&J said it intends to complete its acquisition without a vote or meeting of Omrix's remaining shareholders. Remaining shares will be converted into the right to receive $25 in cash each.

The company said it expects to close the deal as soon as possible. Omrix will then operate as a standalone entity connected to J&J's Ethicon surgical products unit.

Boards of directors of both companies have approved the deal, as has the Israeli government. Omrix's manufacturing operations are based in Tel Aviv.

  • Loading Comments...
  •  

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,274.71 1,086.24 2,125.95 32.11
Oil *
75.50
DOWN
189.69
DOWN
24.39
DOWN
50.10
DOWN
0.68
10 Yr
3.21%
SPDR Gold
113.20
-1.81%
-2.20%
-2.30%
-2.07%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services